|
[1]
|
Stone, J.H., Khosroshahi, A., Deshpande, V., Chan, J.K.C., Heathcote, J.G., Aalberse, R., et al. (2012) Recommendations for the Nomenclature of IgG4‐Related Disease and Its Individual Organ System Manifestations. Arthritis & Rheumatism, 64, 3061-3067. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
张文, 董凌莉, 朱剑, 等. IgG4相关性疾病诊治中国专家共识[J]. 中华内科杂志, 2021, 60(3): 192-206.
|
|
[3]
|
Umehara, H., Okazaki, K., Masaki, Y., Kawano, M., Yamamoto, M., Saeki, T., et al. (2012) A Novel Clinical Entity, IgG4-Related Disease (IgG4RD): General Concept and Details. Modern Rheumatology, 22, 1-14. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Alexander, M.P., Larsen, C.P., Gibson, I.W., Nasr, S.H., Sethi, S., Fidler, M.E., et al. (2013) Membranous Glomerulonephritis Is a Manifestation of IgG4-Related Disease. Kidney International, 83, 455-462. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
费允云, 刘燕鹰, 董凌莉, 向阳, 张文, 赵岩. IgG4相关性疾病诊疗规范[J]. 中华内科杂志, 2023, 62(10): 1161-1171.
|
|
[6]
|
Towheed, S.T., Zanjir, W., Ren, K.Y.M., Garland, J. and Clements-Baker, M. (2024) Renal Manifestations of IgG4‐Related Disease: A Concise Review. International Journal of Nephrology, 2024, Article ID: 4421589. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Capecchi, R., Giannese, D., Moriconi, D., Bonadio, A.G., Pratesi, F., Croia, C., et al. (2021) Renal Involvement in IgG4-Related Disease: From Sunlight to Twilight. Frontiers in Medicine, 8, Article 635706. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Umehara, H., Okazaki, K., Kawa, S., Takahashi, H., Goto, H., Matsui, S., et al. (2021) The 2020 Revised Comprehensive Diagnostic (RCD) Criteria for IgG4-RD. Modern Rheumatology, 31, 529-533. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Tanemoto, F., Mimura, I., Abe, H. and Nangaku, M. (2024) A Case of PLA2R-Positive Membranous Nephropathy with Subsequent Development of IgG4-Related Disease. CEN Case Reports. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Umehara, H., Okazaki, K., Masaki, Y., Kawano, M., Yamamoto, M., Saeki, T., et al. (2012) Comprehensive Diagnostic Criteria for IgG4-Related Disease (IgG4-RD), 2011. Modern Rheumatology, 22, 21-30. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Yunyun, F., Yu, P., Panpan, Z., Xia, Z., Linyi, P., Jiaxin, Z., et al. (2018) Efficacy and Safety of Low Dose Mycophenolate Mofetil Treatment for Immunoglobulin G4-Related Disease: A Randomized Clinical Trial. Rheumatology, 58, 52-60. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Li, J., Peng, Y., Zhang, Y., Zhang, P., Liu, Z., Lu, H., et al. (2020) Identifying Clinical Subgroups in IgG4-Related Disease Patients Using Cluster Analysis and IgG4-RD Composite Score. Arthritis Research & Therapy, 22, Article No. 7. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Wang, L., Zhang, P., Wang, M., Feng, R., Lai, Y., Peng, L., et al. (2018) Failure of Remission Induction by Glucocorticoids Alone or in Combination with Immunosuppressive Agents in IgG4-Related Disease: A Prospective Study of 215 Patients. Arthritis Research & Therapy, 20, Article No. 65. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Ginthör, N.E., Artinger, K., Pollheimer, M.J., Stradner, M.H. and Eller, K. (2021) Membranous Nephropathy Associated with Immunoglobulin G4-Related Disease Successfully Treated with Obinutuzumab. Clinical Kidney Journal, 15, 564-566. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Lanzillotta, M., Fernàndez-Codina, A., Culver, E., Ebbo, M., Martinez-Valle, F., Schleinitz, N., et al. (2021) Emerging Therapy Options for IgG4-Related Disease. Expert Review of Clinical Immunology, 17, 471-483. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Yoshifuji, H. and Umehara, H. (2022) Glucocorticoids in the Treatment of IgG4-Related Disease—Prospects for New International Treatment Guidelines. Modern Rheumatology, 33, 252-257. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Zhang, W. and Stone, J.H. (2019) Management of IgG4-Related Disease. The Lancet Rheumatology, 1, e55-e65. [Google Scholar] [CrossRef] [PubMed]
|